Inventor · disambiguated record
Kuang-Wen Liao
Also filed as: LIAO KUANG-WEN
7 granted patents·10 pending applications·22 citations·filing 2000–2022
76Inventor score
Top patents by PatentIndex Score
17 records- 0182US6699972B1Chimeric protein and method of controlling tumor growth using the proteinACADEMIA SINICA·Filed 2000·Granted Mar 2, 2004·16 cites·4 claims
- 0270US7323450B2Complex immuno-gene medical composition for inhibiting tumor cellsUNIV NAT TAIWAN·Filed 2004·Granted Jan 29, 2008·6 cites·11 claims
- 0363US10808025B2Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibodySAGABIO CO LTD·Filed 2019·Granted Oct 20, 2020·0 cites·2 claims
- 0459US2019381026A1In vivo amelioration of endogenous anti-tumor autoantibodies targeting surface tumor antigens via low-dose p4nUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 0551US8871251B2Liposome and method for producing the sameLIAO KUANG-WEN·Filed 2009·Granted Oct 28, 2014·0 cites·42 claims
- 0651US2023332240A1Method for Predicting Prognosis of Gastric Cancer Patient and Kit ThereforNATIONAL YANG MING CHIAO TUNG UNIV·Filed 2022·Application pending·0 cites
- 0750US12171729B2Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumorsUNIV JOHNS HOPKINS·Filed 2020·Granted Dec 24, 2024·0 cites·21 claims
- 0846US10577409B2Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibodySAGABIO CO LTD·Filed 2016·Granted Mar 3, 2020·0 cites·2 claims
- 0945US2013209542A1Pharmaceutical carrier and pharmaceutical composition for inhibiting angiogenesisUNIV NAT CHIAO TUNG·Filed 2012·Application pending·0 cites
- 1042US2019111040A1In vivo amelioration of endogenous anti-tumor autoantibodies targeting surface tumor antigens via low-dose p4nUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 1141US2013337043A1Composition Used for Thermotherapy and Producing Method Thereof and Method to Treat CancerUROPRO BIOTECH CO LTD·Filed 2013·Application pending·0 cites
- 1239US11306363B2Prognosis biomarkers for triple-negative breast cancerUNIV NATIONAL CHIAO TUNG·Filed 2020·Granted Apr 19, 2022·0 cites·1 claims
- 1338US2013122080A1Pharmaceutical composition capable of immuno-regulation or enhancement of immune responseLIAO KUANG-WEN·Filed 2012·Application pending·0 cites
- 1437US2013266614A1Lipid carrier for delivery of bioactive substance and pharmaceutical compositionLIAO KUANG-WEN·Filed 2012·Application pending·0 cites
- 1535US2003153029A1Bioactive substance secreted by canine transmissible venereal tumor with mammalian B lymphocyte toxicityFiled 2002·Application pending·0 cites
- 1634US2015328183A1Pharmaceutical composition and use for applying 7,7''-dimethoxyagastisflavone in inhibiting tumor metastasisUNIV NAT CHIAO TUNG·Filed 2015·Application pending·0 cites
- 1728US2017342138A1Method for and use of blocking immunosuppressive functions of pathogensSAGABIO CO LTD·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →